BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Metabolism of nitric oxide, Clofibrate, rs4950928, TGFB1, T cell differentiation)
Bookmark Forward

QuickView for CD3e (gene)


Body Atlas

Most Correlated Tissues

  1. Superior cervical ganglion
  2. Appendix
  3. T Lymphocyte (CD8+) of peripheral blood
  4. T Lymphocyte (CD4+) of peripheral blood
  5. Thymus gland
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Contact dermatitis
  2. Sepsis due to Escherichia coli
  3. Toxoplasmosis
  4. Septicemia due to Klebsiella
  5. Hyperglycemia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. NG-Nitroarginine Methyl Ester
  2. artesunate
  3. gp50 protein, Schistosoma
  4. p40 egg antigen, Schistosoma
  5. infliximab
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Notch1
  2. DVL2
  3. CISH
  4. DHX29
  5. LRP5
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Phospho-mimetic CD3ε variants prevent TCR and CAR signaling.
  2. Loss of natural resistance to schistosome in T cell deficient rat.
  3. Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer.
  4. Membrane association of the CD3ε signaling domain is required for optimal T cell development and fun…
  5. CD3ε of a pan T cell marker involved in mouse Aspergillus fumigatus keratitis.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease
  2. VIRTUUS Children's Study
  3. Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)
  4. CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors
  5. Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Pat…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.